Scil Technology GmbH, a German biopharmaceutical development company, and Medtronic’s biologics company, based in Memphis, TN, are partnering in an effort to develop new treatment options for periodontal and bone regeneration. Scil Technology will bring rhGDF-5, a human growth factor, and R&D to the table, while Medtronic will oversee clinical trials, regulatory approvals, and commercialization [...]

[Read more →]